The term "CM2 Antibody" refers to distinct biological entities depending on context, primarily encompassing (1) antibodies targeting the Muscarinic Acetylcholine Receptor 2 (CHRM2) and (2) antibodies against viral CM2 proteins, such as those from human cytomegalovirus (HCMV) or influenza C virus. These antibodies differ in target specificity, structural features, and applications, as detailed below.
Target: CHRM2, a G protein-coupled receptor (GPCR) in the autonomic nervous system and cardiovascular system .
Antibody Type: Monoclonal (e.g., clone 31-1D1) and polyclonal antibodies .
Structure:
HCMV CM2 Antibody: Targets nonstructural HCMV proteins (UL44 and UL57) .
Influenza C CM2 Antibody: Binds to the CM2 ion channel protein, generated from a 374-amino-acid precursor (P42) .
Mechanism: CHRM2 mediates acetylcholine signaling, inhibiting adenylate cyclase and modulating potassium channels .
Research Use:
HCMV CM2: IgM antibodies against CM2/p52 serve as biomarkers for chronic fatigue syndrome (CFS) .
Influenza C CM2: Antibodies target the viral ion channel critical for uncoating and replication .
Cardiovascular Regulation: CHRM2 modulates heart rate and contractility; antibodies aid in studying its role in arrhythmias .
Diagnostic Utility: IgM antibodies against HCMV CM2/p52 are specific to a CFS subset, suggesting persistent viral antigen processing .